Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR

0:0059:01

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:

Introduction: Relative Impact of Targeted Treatment (00:00)
HER2 Alterations (8:04)
KRAS Mutations (24:25)
MET Overexpression (30:34)
ALK Fusions (32:34)
ROS1 Fusions (42:36)
RET Fusions (52:00)